Trond V. Bogsrud

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Clinical Significance of incidental findings of thyroid nodules with increased PSMA-uptake on PET.

Clinical Significance of incidental findings of thyroid nodules with increased PSMA-uptake on PET.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 10, 2026

Substantial decrease in tumor dose over subsequent cyles of [177Lu]Lu-PSMA-radioligand treatment.

Substantial decrease in tumor dose over subsequent cyles of [177Lu]Lu-PSMA-radioligand treatment.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 28, 2025

Reference tissue uptake of [18F]PSMA-1007 in positron emission tomography of recurrent prostate cancer.

Reference tissue uptake of [18F]PSMA-1007 in positron emission tomography of recurrent prostate cancer.

Journal: European radiology

Published: January 14, 2025

Use of choline PET and ultrasound for preoperative localization of hyperfunctioning parathyroid glands: a single-institution retrospective cohort study.

Use of choline PET and ultrasound for preoperative localization of hyperfunctioning parathyroid glands: a single-institution retrospective cohort study.

Journal: Gland surgery

Published: January 10, 2025

I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT.

I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT.

Journal: Clinical nuclear medicine

Published: January 03, 2025

Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy study.

Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy study.

Journal: Medicine

Published: September 10, 2024

¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: August 21, 2024

All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful.

All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful.

Journal: EJNMMI research

Published: August 21, 2024

Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management.

Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management.

Journal: Journal of magnetic resonance imaging : JMRI

Published: July 04, 2023

Diagnostic accuracy of anti-3-[18F]-FACBC PET/MRI in gliomas.

Diagnostic accuracy of anti-3-[18F]-FACBC PET/MRI in gliomas.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 22, 2023

Letter to the Editor: Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer with Dabrafenib.

Letter to the Editor: Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer with Dabrafenib.

Journal: Thyroid : official journal of the American Thyroid Association

Published: May 22, 2023

Diagnostic Value of 18 F-FACBC PET/MRI in Brain Metastases.

Diagnostic Value of 18 F-FACBC PET/MRI in Brain Metastases.

Journal: Clinical nuclear medicine

Published: October 14, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026